Celon Pharma Announces CPL’280, Second Generation Oral GPR40 Agonist, Meets Primary Endpoint in Phase 1 Trial
KIELPIN, Poland, April 01, 2021 (GLOBE NEWSWIRE) -- Celon Pharma S.A. today announced the successful completion of a Phase 1...
KIELPIN, Poland, April 01, 2021 (GLOBE NEWSWIRE) -- Celon Pharma S.A. today announced the successful completion of a Phase 1...
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing of the previously announced divestment...
Allschwil, Switzerland – April 1, 2021Idorsia Ltd (SIX: IDIA) today issued the formal Notice to the upcoming Annual General Meeting...
PRESS RELEASE: REGULATED INFORMATION 1 April 2021, 07:00 CEST Biocartis Announces Publication of 2020 Annual Report Mechelen, Belgium, 1 April 2021...
– Applications are supported by positive PROTECTIVE-2 Phase 3 data demonstrating that plinabulin in combination with G-CSF offers greater protection...
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) -- Solid tumors comprise about 90% of all newly diagnosed cancer cases and...
HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results...
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its...
COLUMBUS, Ohio, March 31, 2021 (GLOBE NEWSWIRE) -- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and certain of its...
FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma Sarclisa regimen...
Vancouver, British Columbia,--(Newsfile Corp. - April 1, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") is pleased...
Oakville, Ontario--(Newsfile Corp. - April 1, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced the appointment of health innovation expert and...
Longtime Healthcare Technology and Digital Health Leader Brings Breadth of Operational Expertise to Support Owlet’s Growth and Expansion LEHI, Utah--(BUSINESS...
DENVER--(BUSINESS WIRE)--Palantir Technologies (NYSE:PLTR) today issued additional details about the Palantir Foundry capabilities it will be highlighting in its Life...
The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with...
LONDON, UK / ACCESSWIRE / April 1, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO)(OTC PINK:HOPHF), the biopharmaceutical group developing new therapies...
MINGO JUNCTION, OHIO / ACCESSWIRE / April 1, 2021 / 1. India's fourth-largest hospital reports thirty overcame covid in three...
Today, MTIP AG, a Basel-based private equity firm that invests in healthtech companies, is pleased to announce that it has...